Zoetis: In-Line Q4 Earnings And Weak Guidance Present A Buying Opportunity
Zoetis' Q4 earnings met expectations, but the stock fell due to slowing growth and cautious 2025 guidance. Click here to find ...
Why Zoetis Stock Took Another Tumble Today
Zoetis slightly topped analyst estimates for profitability and met those for revenue in its fourth quarter. But as investors ...
Zoetis price target lowered to $200 from $225 at BTIG
BTIG lowered the firm’s price target on Zoetis (ZTS) to $200 from $225 and keeps a Buy rating on the shares. The company delivered an in-line ...
Zoetis Avian Influenza Vaccine Secures Conditional Approval In US For Use In Chickens
Zoetis received a USDA conditional license for its H5N2 avian flu vaccine for chickens, marking a step in addressing the ...
Zoetis Earnings Top Analysts' Forecasts
Zoetis exceeded market expectations in Q4 2024, with impressive financial performance despite challenges in specific segments ...
Bank of America Securities Sticks to Their Buy Rating for Zoetis (ZTS)
In a report released today, Michael Ryskin from Bank of America Securities maintained a Buy rating on Zoetis (ZTS – Research Report). The ...
Phibro Animal Health Is Cruising With Its Recent Zoetis Acquisition
Phibro Animal Health projects strong 2025 revenue growth despite debt concerns. Read this artile to know why I think PAHC ...
Why Zoetis Stock Was Falling Today
Shares of Zoetis ( ZTS -6.17%), the leading animal pharmaceutical company, were sliding today after its 2025 guidance came up ...
Why Zoetis Inc. (ZTS) Is Among the Best Drug Stocks to Buy Now
We recently published a list of the 10 Best Drug Stocks to Buy Now. In this article, we are going to take a look at where ...